Tagged with EG

Ukraine Tatyana Pechaeva, Managing Director of the Lekhim Group, one of Ukraine’s top ten domestic pharmaceutical companies, shares the main principles of her strategy which have enabled Lekhim to display high growth rates over recent years despite the country’s unstable economy. The Lekhim group of companies was one of the pioneers…

Indonesia Holger Welters, President Director at Beiersdorf Indonesia, discusses the ambitious growth plan for emerging markets that is propelling the company to new heights and sheds light on the importance of bringing high quality skincare solutions to Indonesia through Nivea® and Hansaplast®. Mr. Welters, you have been President Director of Beiersdorf’s…

Taiwan Eugene Huang, chairman, and Hua-Lin Wu, consultant of Blue Blood Biotech Corp., provide insightful information on BB-101, a protein proven to be efficient for wound healing, while sharing their vision for the future growth of the company through partnerships with big pharmaceutical companies. Could you introduce yourself to our executive…

Colombia Aurobindo’s regional head, Kamlesh Thakkar, discusses how the company is truly benefiting the healthcare landscape in Colombia, while describing his experience in changing the mindset concerning the use of generics in the top hospitals of the country and shares the origins of Aurobindo’s healthier life campaign. To begin, Mr. Thakkar,…

Taiwan Ken-Shwo Dai, president and CEO of Visgeneer, explains his biotech’s expertise in medtech, skincare, gene therapy and diagnostics, as well as his plans to take the company public. Can you introduce yourself and Visgeneer to our readers? What have been the main milestones for the company so far? “Visgeneer believes that…

Taiwan Jassy Wang, CEO of MegaPro Biomedical, a nanomedicine development company specializing in developing nanoparticles and nanomicelles, discusses the evolving nanomedicine market in Taiwan and reveals the company’s plans for future growth. Can you introduce MegaPro Biomedical to our readers? “Nanosize features many advantages; amongst them I would highlight the ability…

Ukraine Victoria Tarabanova, country manager of the Ukrainian office of Wörwag Pharma, a company dedicated to treating diabetic comorbidities such as neuropathic, cardiovascular and neurological diseases, provides insights into the company’s remarkable efforts to enhance Ukraine’s health ecosystem and its enduring commitment to Ukrainian patients and physicians – even during the…

Colombia Spearheading the Colombian affiliate of the global leader in oncology, Carlos Estrada, General Manager of Roche Colombia shares his insights on the profound transformations of the Colombian healthcare system. He speaks about achieving optimal equilibrium in the system, the exciting pipeline ahead for Roche, as well as their strategies to…

Ukraine Dr. Natalya Gudz, head of the State Service of Ukraine on Medicines and Drugs Control (SMDC), provides her vision for the development of Ukraine’s key regulatory authority and the win-win relationship she wants to bolster between the pharmaceutical and healthcare companies operating in Ukraine and SMDC’s international counterparts. You took…

Ukraine Denis Shevchenko, founder of the NGO and charitable foundation PharmVarta, provides insights into the main initiatives of this independent, non-profit organization that has freely supplied Ukrainian patients with more than 1.5 million packs over the past 18 months, while he also highlights some critical regulatory updates that could further improve…

Switzerland Roel Van Doren provides a fascinating insight into the interplay between the life sciences and industrial automation sectors in Europe, whilst also detailing Emerson’s footprint in Switzerland and beyond, as well as the company’s latest innovations. We understand you have been European President at Emerson Automation Solutions since 2012. What…

Ukraine Dr. Volodymyr Redko, executive director of Ukraine’s Association of Pharmaceutical Research and Development (APRaD), which gathers together 15 international R&D-driven companies, provides insights into the perspective of international innovators vis-à-vis the numerous regulatory and structural reforms that are set to transform the country’s health system, while highlighting the importance that…